Vaccine

Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort
Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026
Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026
Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
Pfizer Shares Are Down Today: What's Going On?
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst

Vaccine Recent News

Mpox Declared A Global Public Health Emergency By WHO Amid Rapid International Spread
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
The funds will be utilized to finalize the late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
The initiative focuses on commercializing academic research aimed at preventing deadly fentanyl from reaching the brain.
CureVac, GSK Partner Release Data On Influenza Vaccine Study
CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A strains prompt further optimization for influenza B strains.
Marjorie Taylor Greene Faces Democratic Criticism Over 'Vulgarity' And 'Conspiracy' In Vaccine Hearing
Greene, who is not a medical professional, claimed to have a "Ph.D. in recognizing bullshit" during a hearing on vaccine safety and public trust in vaccinations.
With Healthier Finances, Clover Bio Shifts To Flu And RSV Vaccines
Key Takeaways: Clover Biopharmaceuticals posted a surge in first-half earnings after a $384 million grant for Covid vaccine development was belatedly folded into its accounts The company has turned its attention to flu vaccines after being hit by waning demand in the crowded Covid market By Molly Wen
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.
FDA Approves New Technique To Extend Supply Of Monkeypox Vaccine: Report
A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses has been approved by the Food and Drug Administration.
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
As COVID-19 continues to mutate and form new variants, the FDA is calling on the major vaccine manufacturers to create a new composition of the vaccine for adults.
Novavax's COVID-19 Vaccine For Adults Over 18 Backed By FDA Advisors: What's Next?
Novavax, Inc. (NASDAQ: NVAX) announced the U.S.
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
Here's a roundup of top developments in the biotech space over the last 24 hours:
COVID Booster Dose No Longer Required For Employees Of This Tech Giant In US Offices
Meta Platforms Inc (NASDAQ: FB) recently announced that the company no longer requires employees to have COVID-19 booster shots to enter its offices in the U.S. 
Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock
Key takeaways: Jiangsu Recbio has filed a second IPO application to list in Hong Kong, hoping to become the first HPV vaccine maker in the market The company was valued at around 9 billion yuan after its latest funding round By Molly Wen
BofA Downgrades CureVac On Limited 2022 Prospects
There is limited upside from CureVac BV’s (NASDAQ: CVAC) COVID-19 vaccine and there are few catalysts from the rest of the company’s pipeline in 2022, according to BofA Securities.
What The Future Might Hold For Novavax Stock
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday after Australia’s national drug regulator granted approval for the company's COVID-19 vaccine. The stock is trading below what traders call a pennant pattern and is showing uncertainty in where it could head next.
Apple To Require Proof Of COVID Booster Shot For Store And Corporate Employees
Apple Inc (NASDAQ: AAPL) has asked its store as well as corporate employees to get a COVID-19 booster shot. 
Novak Djokovic Leaves Australia After Losing Visa Appeal; Serbian President Says Aussies 'Humiliated Themselves'
Serbian tennis star Novak Djokovic has left Australia after losing an appeal to stay in the country and seek his tenth Australian Open championship despite being unvaccinated against COVID-19.
10 Best Performing S&P 500 Stocks Of 2021
The S&P 500 delivered one of its best years in recent history in 2021, gaining more than 27%. Most U.S. investors had a lot of winners in their portfolios this year, but some stocks certainly performed better than others. Here’s a look at the 10 best-performing stocks in the entire S&P 500 in 2021.

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved